The third set of papers out this week from The Cancer Genome Atlas touches on ways to cluster tumors, oncogenic processes that contribute to oncogenesis, and more.
As part of the agreement, a precision cancer research and treatment institute will be created at the Windber facilities.
BioServe touts the repository as the "the largest resource of high-quality biosamples for the life science industry" and claims that researchers can access it to garner biosamples from "most any major diseases."
The firm has started the BioServe Network with partners including Fox Chase, Windber, UMass, and the Fairbanks Institute for Healthy Communities.
BioServe will supplement its clinical-grade biospecimens in its Global BioRepository with biosamples from the Windber Research Institute's Tissue Bank.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.